Enhanced NK-cell development and function in BCAP-deficient mice

Blood

Volumn 112, Issue 1, 2008, Pages 131-140

  MacFarlane IV, Alexander W ^a   Yamazaki, Tetsuo ^b   Fang, Min ^a   Sigal, Luis J ^a   Kurosaki, Tomohiro ^c   Campbell, Kerry S ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b KYOTO UNIVERSITY   (Japan)

^c RIKEN Center for Integrative Medical Sciences   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MEMBRANE PROTEIN; PROTEIN BCAP; UNCLASSIFIED DRUG; GAMMA INTERFERON; PHOSPHATIDYLINOSITOL 3 KINASE; PIK3AP1 PROTEIN, MOUSE; PROTEIN KINASE B; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANIMAL TISSUE; ARTICLE; B LYMPHOCYTE; CELL FUNCTION; CELL MATURATION; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; ANIMAL; APOPTOSIS; BIOLOGICAL MODEL; BIOSYNTHESIS; C57BL MOUSE; CELL AGING; CELL DIFFERENTIATION; CONGENIC STRAIN; CYTOLOGY; CYTOTOXICITY; FEMALE; GENETICS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MALE; METABOLISM; MOUSE MUTANT; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; APOPTOSIS; CELL AGING; CELL DIFFERENTIATION; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; HUMANS; INTERFERON TYPE II; KILLER CELLS, NATURAL; MALE; MICE; MICE, CONGENIC; MICE, INBRED C57BL; MICE, KNOCKOUT; MODELS, IMMUNOLOGICAL; PROTO-ONCOGENE PROTEINS C-AKT; SELF TOLERANCE; SIGNAL TRANSDUCTION;

EID: 47249118882     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2007-08-107847     Document Type: Article

References (50)

1. Ljunggren HG, Karre K. In search of the 'missing self: MHC molecules and NK cell recognition. Immunol Today. 1990;11:237-244.
2. Kane KP, Lavender KJ, Ma BJ. Ly-49 receptors and theirfunctions. Crit Rev Immunol. 2004;24:321-348.
3. Kubota A, Kubota S. Lohwasser S, Mager DL, Takei F. Diversity of NK cell receptor repertoire in adult and neonatal mice. J Immunol. 1999;163:212-216.
4. Held W. Kunz B. An allele-specific. stochastic gene expression process controls the expression of multiple Ly49 family genes and generates a diverse, MHC-specific NK cell receptor repertoire. Eur J Immunol. 1998;28:2407-2416.
5. Salcedo M, DiehlAD, Olsson-Alheim MY, et al. Altered expression of Ly49 inhibitory receptors on natural killer cells from MHC class l-deficient mice. J Immunol. 1997;158:3174-3180.
6. Lowin-Kropf B, Held W. Positive impact of inhibitory Ly49 receptor-MHC class l interaction on NK cell development. J Immunol. 2000;165:91-95.
7. Roth C, Garlyle JR, Takizawa H, Raulet DH. Clonal acquisition of inhibitory Ly49 receptors on developing NK cells is successively restricted and regulated by stromal class l MHC. Immunity. 2000;13:143-153.
8. Fahlen L Lendahl U, Sentman CL. MHC class I-Ly49 interactions shape the Ly49 repertoire on murine NK cells. J Immunol. 2001;166:6585-6592.
9. Hanke T Takizawa H, Raulet DH. MHC-dependent shaping of the inhibitory Ly49 receptor repertoire on NK cells: evidence for a regulated sequential model. Eur J Immunol. 2001:31:3370-3379.
10. Held W, Dorfman JR, Wu M F, Raulet DH. Major histocompatibility complex class l-dependent skewing of the natural killer cell Ly49 receptor repertoire. Eur J Immunol. 1996;26:2286-2292.
11. Valiante NM, Uhrberg M, Shilling HG, et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. Immunity. 1997;7:739-751.
12. Dorfman JR, Raulet DH. Major histocompatibility complex genes determine natural killer cell tolerance. Eur J Immunol. 1996;26:151-155.
13. Fernandez NG, Treiner E, Vance RE, Jamieson AM. Lemieux S, Raulet DH. Asubset of natural killer cells achieves self-tolerance without expressing inhibitory receptors specific for self-MHC molecules. Blood. 2005;105:4416-4423.
14. Anfossi N, Andre P, Guia S, etal. Human NK cell education by inhibitory receptors for MHC class l. Immunity. 2006;25:331-342.
15. Kim S, Poursine-Laurent J, Truscott SM, et al. Licensing of natural killer cells by host major histocompatibility complex class l molecules. Nature. 2005;436:709-713.
16. Cooley S, Xiao F, Pitt M. et al. Asubpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self MHC is developmentally immature. Blood. 2007;110:578-586.
17. Liao NS, Bix M, Zijlstra M, Jaenisch R, Raulet D. MHC class l deficiency: susceptibility to natural killer (NK) cells and impaired NK activity. Science. 1991;253:199-202.
18. Bonnerna JD, Karnitz LM, Schoon RA, Abraham RT Leibson PJ. Fc receptor stimulation of phosphatidylinositol 3-kinase in natural killer cells is associated with protein kinase C-independent granule release and cell-mediated cytotoxicity. J Exp Med. 1994;180:1427-1435.
19. Jiang K, Zhong B, Gilvary DL et al. Pivotal role of phosphoinositide-3 kinase in regulation of cytotoxicity in natural killer cells. Nat Immunol. 2000;1:419-425.
20. Jiang K, Zhong B, Ritchey C, et al. Regulation of Akt-dependent cell survival by Syk and Rac. Blood. 2003;101:236-244.
21. Kurosaki T Regulation of B-cell signal transduction by adaptor proteins. Nat Rev Immunol. 2002; 2:354-363. 22.
22. Okada T Maeda A, IwamatsuA, Gotoh K, Kurosaki T. BCAP: the tyrosine kinase substrate that connects B cell receptor to phosphoinositide 3-kinase activation. Immunity. 2000;13:817-827.
23. Yamazaki T Takeda K. Gotoh K, Takeshima H, Akira S, Kurosaki T. Essential immunoregulatory role for BCAP in B cell development and function. J Exp Med. 2002;195:535-545.
24. Yamazaki T, Kurosaki T. Contribution of BCAP to maintenance of mature B cells through c-Rel. Nat Immunol. 2003;4:780-786.
25. Brennan J, Lemieux S, Freeman JD. Mager DL, Takei F Heterogeneity among Ly-49C natural killer (NK) cells: characterization of highly related receptors with differing functions and expression patterns. J Exp Med. 1996;184:2085-2090.
26. Scarpellino L, Oeschger F, Guillaume P, et al. Interactions of Ly49 family receptors with MHC class l ligands in trans and cis. J Immunol. 2007; 178:1277-1284.
27. Yusa S, Catina TL, Campbell KS. SHP-1-and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells. J Immunol. 2002;168:5047-5057.
28. Arase N, Arase H, Park SY, Ohno H, Ra C, Saito T. Association with FcRgamma is essential for activation signal through NKR-P1 (CD161) in natural killer (NK) cells and NK1.1 + T cells. J Exp Med. 1997;186:1957-1963.
29. Okkenhaug K, Vanhaesebroeck B. PI3K-signalling in B-and T-cells: insights from gene-targeted mice. Biochem Soc Trans. 2003;31:270-274.
30. Inabe K, Kurosaki T. Tyrosine phosphorylation of B-cell adaptor for phosphoinositide 3-kinase is required for Akt activation in response to CD19 engagement. Blood. 2002;99:584-589.
31. Hayakawa Y, Smyth MJ. CD27 dissects mature NK cells into two subsets with distinct responsiveness and migratory capacity. J Immunol. 2006; 176:1517-1524.
32. Huntington ND, Tabarias H, Fairfax K, et al. NK cell maturation and peripheral homeostasis is associated with KLRG1 up-regulation. J Immunol. 2007;178:4764-4770.
33. Kim S, lizuka K, Kang HS, et al. In vivo developmental stages in murine natural killer cell maturation. Nat Immunol. 2002;3:523-528.
34. Di Santo JP. Natural killer cell developmental pathways: a question of balance. Annu Rev Immunol. 2006;24:257-286.
35. Hayakawa Y, Huntington ND, Nutt SL, Smyth MJ. Functional subsets of mouse natural killer cells. Immunol Rev. 2006;214:47-55.
36. Perarnau B, Saron MF, San Martin BR, et al. Single H2Kb, H2Db and double H2KbDb knockout mice: peripheral CD8+Tcell repertoire and anti-lymphocytic choriomeningitis virus cytolytic responses. Eur J Immunol. 1999;29:1243-1252.
37. Jacoby RO, Bhatt PN, Brownstein DG. Evidence that NK cells and interferon are required for genetic resistance to lethal infection with ectromelia virus. Arch Virol. 1989;108:49-58.
38. Fang M, Lanier LL, Sigal LJ. A role for NKG2D in NK cell-mediated resistance to poxvirus disease. Plos Pathogens. 2008;4:1-11.
39. Parker AK, Parker S, Yokoyama WM, Corbett JA, Buller RM. Induction of natural killer cell responses by ectromelia virus controls infection. J Virol. 2007;81:4070-4079.
40. Reichlin A, Hu Y, Meffre E, et al. B cell development is arrested at the immature B cell stage in mice carrying a mutation in the cytoplasmic domain of immunoglobulin beta. J Exp Med. 2001;193:13-23.
41. Tze LE, Schram BR, Lam KP, et al. Basal immunoglobulin signaling actively maintains developmental stage in immature B cells. PLoS Biol. 2005;3:e82.
42. Hayakawa K, Asano M, Shinton SA, et al. Positive selection of natural autoreactive B cells. Science. 1999;285:113-116.
43. Wen L, Brill-Dashoff J, Shinton SA, Asano M, Hardy RR, Hayakawa K. Evidence of marginalzone B cell-positive selecti on in spleen. Immunity. 2005;23:297-308.
44. Raulet DH, Vance RE. Self-tolerance of natural killer cells. Nat Rev Immunol. 2006;6:520-531.
45. Lowin-Kropf B, Kunz B, Beermann F, Held W. Impaired natural killing of MHC class l-deficient targets by NK cells expressing a catalytically inactive form of SHP-1. J Immunol. 2000;165:1314-1321.
46. Johansson S, Johansson M, Rosmaraki E, et al. Natural killer cell education in mice with single or multiple major histocompatibility complex class I molecules. J Exp Med. 2005;201:1145-1155.
47. Hardy RR, Hayakawa K. B cell development pathways. Annu Rev Immunol. 2001;19:595-621.
48. Wang D, Feng J, Wen R, et al. Phospholipase Cgamma2 is essential in the functions of B cell and several Fc receptors. Immunity. 2000;13:25-35.
49. Cella M, Fujikawa K, Tassi I, et al. Differential requirements for Vav proteins in DAP10-and ITAM-mediated NK cell cytotoxicity. J Exp Med. 2004;200:817-823.
50. Tassi I, Presti R, Kim S, Yokoyama WM, Gilfillan S, Colonna M. Phospholipase C-gamma 2 is a critical signaling mediator for murine NK cell activating receptors. J Immunol. 2005;175:749-754.